These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26795234)

  • 21. A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes.
    Beeton C; Wulff H; Singh S; Botsko S; Crossley G; Gutman GA; Cahalan MD; Pennington M; Chandy KG
    J Biol Chem; 2003 Mar; 278(11):9928-37. PubMed ID: 12511563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acacetin blocks kv1.3 channels and inhibits human T cell activation.
    Zhao N; Dong Q; Fu XX; Du LL; Cheng X; Du YM; Liao YH
    Cell Physiol Biochem; 2014; 34(4):1359-72. PubMed ID: 25301362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants.
    Pegoraro S; Lang M; Dreker T; Kraus J; Hamm S; Meere C; Feurle J; Tasler S; Prütting S; Kuras Z; Visan V; Grissmer S
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2299-304. PubMed ID: 19282171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
    Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
    Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells.
    Kahlfuß S; Simma N; Mankiewicz J; Bose T; Lowinus T; Klein-Hessling S; Sprengel R; Schraven B; Heine M; Bommhardt U
    Mol Cell Biol; 2014 Mar; 34(5):820-31. PubMed ID: 24344200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone Deacetylases Enhance Ca
    Matsui M; Terasawa K; Kajikuri J; Kito H; Endo K; Jaikhan P; Suzuki T; Ohya S
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions.
    Chiang EY; Li T; Jeet S; Peng I; Zhang J; Lee WP; DeVoss J; Caplazi P; Chen J; Warming S; Hackos DH; Mukund S; Koth CM; Grogan JL
    Nat Commun; 2017 Mar; 8():14644. PubMed ID: 28248292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
    Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
    Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18β-Glycyrrhetinic acid potently inhibits Kv1.3 potassium channels and T cell activation in human Jurkat T cells.
    Fu XX; Du LL; Zhao N; Dong Q; Liao YH; Du YM
    J Ethnopharmacol; 2013 Jul; 148(2):647-54. PubMed ID: 23707333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity.
    Wulff H; Knaus HG; Pennington M; Chandy KG
    J Immunol; 2004 Jul; 173(2):776-86. PubMed ID: 15240664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in healthy pregnancy and preeclampsia.
    Toldi G; Stenczer B; Treszl A; Kollár S; Molvarec A; Tulassay T; Rigó J; Vásárhelyi B
    Am J Reprod Immunol; 2011 Feb; 65(2):154-63. PubMed ID: 20649894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
    Hu L; Pennington M; Jiang Q; Whartenby KA; Calabresi PA
    J Immunol; 2007 Oct; 179(7):4563-70. PubMed ID: 17878353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of Kv1.3 and IKCa1 channel inhibition on cytokine production and calcium influx of T lymphocytes in rheumatoid arthritis and ankylosing spondylitis.
    Toldi G; Munoz L; Herrmann M; Schett G; Balog A
    Immunol Res; 2016 Apr; 64(2):627-31. PubMed ID: 26280090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. K
    Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
    Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of Kv1.3 channels ameliorates radiation-induced brain injury.
    Peng Y; Lu K; Li Z; Zhao Y; Wang Y; Hu B; Xu P; Shi X; Zhou B; Pennington M; Chandy KG; Tang Y
    Neuro Oncol; 2014 Apr; 16(4):528-39. PubMed ID: 24305723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Interleukin-10 Expression by the Inhibition of Ca
    Ohya S; Matsui M; Kajikuri J; Endo K; Kito H
    J Pharmacol Exp Ther; 2021 Apr; 377(1):75-85. PubMed ID: 33504590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation.
    Beeton C; Smith BJ; Sabo JK; Crossley G; Nugent D; Khaytin I; Chi V; Chandy KG; Pennington MW; Norton RS
    J Biol Chem; 2008 Jan; 283(2):988-97. PubMed ID: 17984097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
    Hua X; Deuse T; Chen YJ; Wulff H; Stubbendorff M; Köhler R; Miura H; Länger F; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2013 Jan; 95(2):285-92. PubMed ID: 23325003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Voltage-dependent potassium channel and calcium-activated potassium channel current changes of peripheral blood T-lymphocytes from hypertensive patients in Xinjiang Kazakh].
    Zhang QB; Zhang YM; Cheng LF; Yuan QY; Zhang GM; Liang P; Gou F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Dec; 41(12):1020-4. PubMed ID: 24524604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of lymphocyte kv1.3-channels in the pathogenesis of renal diseases and novel therapeutic implications of targeting the channels.
    Kazama I
    Mediators Inflamm; 2015; 2015():436572. PubMed ID: 25866450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.